*仅供医学专业人士阅读参考“日防夜防，家贼难防”，内鬼任何时候都让人头疼，当然也被恨得咬牙切齿，但又几乎是必然存在的。在抗癌这条战线上，都不说免疫细胞整体纯纯的某黑衣酒厂了，就算是限定到T细胞乃至CD8+T细胞，那肯定也有给抗癌战友拖后腿的家伙，得早 ...

The phase 2 CELLVX-230 trial is assessing the potential of FK-PC101 to prevent prostate cancer recurrence and delay ...

Cervical cancer remains a global health burden ... This study underscores the feasibility of using metastatic lymph nodes as ideal sources for high-quality TIL production. Attributes such as a ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, today announces that it has commenced a Phase Ib study evaluating MOv18 IgE in patients with ...

StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the biotechnology ...